Hims & Hers strikes a deal with Novo Nordisk to sell Wegovy — and the stock soars 28%
Telehealth company Hims & Hers (HIMS) announced Tuesday that it will begin selling Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy.Read more...
Hims & Hers will get to sell Ozempic. Like, real Ozempic. The stock soa
Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo's blockbuster GLP-1 drug Wegovy
[...]
Wegovy sales took a hit this year. Novo's CEO blames off-brand competi
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/80d83acceff64c4fc5851e3ab8f802f1.jpg"/><p>Sales of Novo Nordisk’s (<a cla [...]